55382-14-4 Usage
Uses
Used in Pharmaceutical Industry:
(2S,3R)-2-benzyloxycarbonylamino-3-(3,4-dibenzyloxyphenyl)-3-hydroxypropioic acid is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the chemical industry, (2S,3R)-2-benzyloxycarbonylamino-3-(3,4-dibenzyloxyphenyl)-3-hydroxypropioic acid serves as a key reactant in the preparation and synthesis of various organic compounds, including those with potential applications in materials science and specialty chemicals.
Used in Research and Development:
(2S,3R)-2-benzyloxycarbonylamino-3-(3,4-dibenzyloxyphenyl)-3-hydroxypropioic acid is also utilized in research and development settings, where it can be employed to study the properties and reactivity of complex organic molecules. Its unique structure makes it a valuable tool for understanding the behavior of similar compounds and for developing new synthetic methods.
Used in the Synthesis of Exochelin and its Hydrophenyl-based Analogs:
(2S,3R)-2-benzyloxycarbonylamino-3-(3,4-dibenzyloxyphenyl)-3-hydroxypropioic acid is a reactant in the preparation and synthesis of exochelin and its hydrophenyl-based analogs. These compounds have potential applications in various fields, including pharmaceuticals and biotechnology.
Used as a Protected DL-threo-Droxidopa:
Derived from 3,4-Di-O-benzyl DL-threo-Droxidopa Hydrochloride (D417530), which is a protected form of DL-threo-Droxidopa, an antiparkinsonian agent, (2S,3R)-2-benzyloxycarbonylamino-3-(3,4-dibenzyloxyphenyl)-3-hydroxypropioic acid plays a crucial role in the development of treatments for Parkinson's disease.
Check Digit Verification of cas no
The CAS Registry Mumber 55382-14-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,3,8 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 55382-14:
(7*5)+(6*5)+(5*3)+(4*8)+(3*2)+(2*1)+(1*4)=124
124 % 10 = 4
So 55382-14-4 is a valid CAS Registry Number.
55382-14-4Relevant academic research and scientific papers
Resolution method of droxidopa key intermediates
-
Paragraph 0010; 0021; 0022; 0025, (2019/07/16)
The invention relates to a resolution method of droxidopa threo type key intermediates (key intermediate I, key intermediate II and key intermediate III in synthetic routes 1, 2 and 3), which is characterized in that a non-alkaloid, commercially available
PROCESSES FOR THE PREPARATION OF DIASTEREOMERICALLY AND ENANTIOMERICALLY ENRICHED OXAZOLINES
-
, (2017/05/28)
The invention relates to an industrially viable and advantageous process for the preparation of (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid, having the following formula (I) generally known as Droxidopa, or of intermediates useful in the synthesis thereof.
Total synthesis of exochelin MN and analogues.
Dong,Miller, Marvin J
, p. 4759 - 4770 (2007/10/03)
The first total synthesis of exochelin MN is described along with rationally designed analogues. The required L-threo-beta-hydroxyamino acid components were constructed using either Sharpless asymmetric aminohydroxylation reactions or an aldol reaction of imidazolidinone 19. A new concise procedure for the preparation of the constituent six-membered cyclic hydroxamate was developed. In addition, a plausible mechanism for exochelin MN-mediated iron(III) transport was proposed. Biological studies of these compounds will be used to evaluate this hypothesis.
